GreenClinic LifeScience

What GreenClinic LifeScience does

GreenClinic LifeScience (GCLS) operates as an independent international competence center delivering applied ecosystem, biodiversity, and plant pathology services based on metagenomics, data science, and an AI-powered knowledge base. The company is a subsidiary brand within the GNerdiX OÜ group following a 2022 rebranding, with its primary legal entity being GreenClinic LifeScience Ukraine, LLC (Registry Code 40569905), plus entities in Poland (GreenClinic LifeScience Sp. z o.o.) and Estonia. Its flagship technical product is BioFiling™, a DNA-based soil and plant microbiome profiling test positioned as the world's first standard analysis for routine soil biological fertility testing, developed 2009–2015 and launched commercially in 2019. The service portfolio includes Preventive Ecosystem Phytopathology 360° (HACCP-based), Global Ecosystem Phytopathology Service, Plant Clinic – Plants' Health Care 360°, e-Phytopathology (electronic advisory opinions), Phytopathological Forensic (root cause analysis), Right Seeds 2 Right Fields (pre-seed DNA pathogen profiling for crop variety selection), and broader biodiversity research and climate change adaptation services.

Revenue is generated through professional services contracts — custom contract research, on-site examinations, advisory opinions, and BioFiling™ microbiome testing — delivered under quote-based, multi-year contracts. The customer base is diversified across large agribusinesses, forestry operators, municipalities, landscapers, and residential plant owners, with large enterprise customers served directly and retail/small customers reached through an international network of owned and partnered Centers of Ecosystem Phytopathology (plant clinics). The company also operates infrastructure platforms including HUBBSA, an 80-hectare research hub and experimental farm station in Ukraine, and GreenClinic LifeScience Academy, an educational platform.

Name

GreenClinic LifeScience

Legal name

GreenClinic LifeScience Ukraine, LLC

Website

https://greenclinicglobal.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

11–50 employees

Short description

GreenClinic LifeScience delivers applied ecosystem phytopathology and soil microbiome testing services using metagenomics and an AI-powered knowledge base, serving large agribusinesses, forestry operators, municipalities, and residential plant owners globally via custom contract research and licensed partners.

Ownership category

akta.pro rank

Product category

Plant Pathology & Soil Microbiome Services

NAICS

Soil Preparation, Planting, and Cultivating (115112), Environmental Consulting Services (541620)

SIC

Agricultural Services (700), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Soil Health & Biological Testing Services (Microbial Activity, Organic Matter, Respiration) (AFACAKAD)

akta.pro secondary industries

Microbiome & Metagenomics Services (HLAGANAH), Nutrient Stewardship & Soil Fertility Management (4R Nutrients, Compost, Biofertilizers) (AFAGAMAE), Carbon, Sustainability & Farm Certification Support (Agro-Environmental Advisory) (AFACABAL)

Keywords

• Soil microbiome testing
• Plant pathology services
• Agricultural research services
• Biodiversity research
• Ecosystem phytopathology

Headquarters

HQ city

Kraków

HQ country

Poland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Ecosystem Phytopathology Research Services: Contract research services for plant pathology support including on-site examinations documented in protocols, advisory opinions with recommendations and action plans. Services provided globally to agribusinesses, forestry, and landscaping customers.
2. Soil & Plants Microbiome Testing Services: DNA-based microbiome profiling analysis services including BioFiling™ standard test and tailor-made orders for applied microbiome research. Provides soil biological fertility testing and BioFiling Plants for pathogen definition inside plants.
3. Scientific Decision Support Services: Custom contract researches and research products tailored to cover the need for reliable high quality data and expert support for decision making and implementation. Covers bioeconomy, agriculture, medicine, wellbeing, safety, sustainable infrastructure and renewables.
4. Right Seeds 2 Right Fields Service: High precision choice of crop varieties and hybrids for field growing conditions based on resistance profile matching phytopathological threat profiles of fields.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

GreenClinic LifeScience delivers Ecosystem Phytopathology as a Service, providing DNA-based soil and plant microbiome profiling (BioFiling™), plant disease diagnostics, preventive ecosystem phytopathology advisory, biodiversity research, and phytopathological forensic services. Its customers are agribusinesses, foresters, landscaping and municipal green-services operators, and households seeking independent, science-driven plant and soil health expertise.

Product overview

GreenClinic LifeScience operates as an independent international competence center delivering industrial value through applied ecosystem, biodiversity, and plant pathology knowledge based on metagenomics and data science. The core offering centers on Ecosystem Phytopathology as a Service, comprising BioFiling™ Soil and Plants Microbiome Profiling Test (the world's first standard for routine soil biological fertility testing) as the foundational diagnostic tool. This is supported by preventive and reactive plant health services including Plant Clinic – Plants' Health Care 360°, Global Ecosystem Phytopathology Service, and e-Phytopathology electronic advisory platform. The Right Seeds 2 Right Fields pre-seed DNA pathogen profiling enables precision agriculture decisions. The company also maintains research infrastructure platforms including HUBBSA (80-hectare experimental farm), Urban Biodiversity Research Center, and a network of Centres for Ecosystem Phytopathology. Additional services span climate change adaptation, biodiversity research for construction, scientific decision support, and the GreenClinic LifeScience Academy educational platform. The portfolio is tied together by an AI-powered knowledge base and biodata processing system.

Differentiator

Problem solved

Functional benefit

Brands

• BioFiling™: World's first standard analysis for routine soil biological fertility testing, a DNA-based soil micro biodiversity analysis delivering wide, detailed and precise soil microbiota profile.
• e-Phytopathology
• EVIM
• WasteInForum

Products and services

• BioFiling™ Soil and Plants Microbiome Profiling Test

Quantifiable outcome

• 78% higher profits with regenerative agriculture according to research by Claire LaCanne and Dr. Jonathan Lundgren
• +1 more outcomes

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• GNerdiX OÜcoreStrategic or Co-development Partner · 1 January 2021GNerdiX OÜ (Estonia) founded HUBBSA research hub and is the parent company following rebranding of GreenClinic LifeScience Global OÜ. GNerdiX represents the brands internationally and backs GNerdiX projects with research infrastructure.
• HUBBSA Partner FarmscoreStrategic or Co-development Partner · 1 January 2021Two partner farms uniquely located in the forest steppe and steppe zones, directly neighboring each other, 100km south of Kyiv Boryspil Airport. Support HUBBSA experimental farm station operations.
• GreenClinic LifeScience Ukraine, LLCcoreOthersR&D and project management center located in Kyiv, Ukraine. Founded by initiative of GreenClinic LifeScience and GNerdiX OÜ. Represents brands in Ukraine, manages national market operations, maintains research infrastructure.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• AgBiome: AgBiome is an established agricultural biologicals and crop protection company using microbial discovery; its platform overlaps with GCLS's microbiome-informed plant health advisory.
• SGS SA: SGS operates a global agricultural testing and inspection network including soil and plant health services, comparable to GCLS as a contract research/testing provider serving agribusiness and forestry.
• Eurofins Scientific: Eurofins is a global contract testing and laboratory services group with agricultural soil, plant and microbiome testing capabilities, comparable as a scaled commercial research provider to GCLS's contract research offerings.
• Indigo Ag: Indigo Ag is a larger digital agriculture and microbial products platform; its soil health and microbiome-enabled agronomy offerings overlap with GCLS's biotech-driven crop advisory services.
• Bayer Crop Science: Bayer Crop Science is a major incumbent in crop protection, seeds and digital farming (Climate FieldView), broadly overlapping with GCLS's agribusiness and digital decision-support positioning.

Direct peers

• Pattern Ag: Pattern Ag analyzes soil and crop microbiomes with metagenomics to predict pest and pathogen pressure, closely paralleling GCLS's Right Seeds 2 Right Fields and Phytopathological Forensic services.
• Trace Genomics: Trace Genomics provides soil DNA sequencing and analytics for agribusinesses and agronomists, overlapping directly with GCLS's microbiome-based crop diagnostics and field decision-support offerings.
• Biome Makers: Biome Makers applies DNA sequencing and AI to soil microbiome analysis for agriculture (BeCrop®), directly mirroring GCLS's BioFiling™ DNA-based soil biodiversity profiling and agronomic advisory positioning.

Emerging players

• Concentric Ag: Concentric Ag develops microbial products and soil-health analytics leveraging root and soil microbiome science, overlapping with GCLS's biological-soil-fertility and microbiome diagnostics work.

Regional players

• NRGene: NRGene provides genomics and bioinformatics for crop breeding and ag-input companies, technologically comparable to GCLS's metagenomics/DNA-based analytics though focused on genomics rather than soil microbiome diagnostics.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/gclsg
• Facebookfacebook.com/greencliniclifescienceukraine
• LinkedInlinkedin.com/company/gcls

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GreenClinic LifeScience